Characterization of a cyclophosphamide-induced murine model of immunosuppression to study Acinetobacter baumannii pathogenesis

Journal of Medical Microbiology

Volumn 62, Issue PART 11, 2013, Pages 1747-1754

  Manepalli, Swetha ^a   Gandhi, Jay A ^a   Ekhar, Vaibhav V ^a   Asplund, Melissa B ^a   Coelho, Carolina ^b,c   Martinez, Luis R ^a,b  

^a LONG ISLAND UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; CYTOKINE RELEASE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LIMIT OF DETECTION; LUNG DISEASE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PATIENT CARE; PNEUMONIA; PRIORITY JOURNAL; PUBLIC HEALTH; SYSTEMIC DISEASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; PNEUMONIA, BACTERIAL; SEPSIS;

EID: 84885929293     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.060004-0     Document Type: Article

References (19)

1. Adams, M. D., Goglin, K., Molyneaux, N., Hujer, K. M., Lavender, H., Jamison, J. J., MacDonald, I. J., Martin, K. M., Russo, T. & other authors (2008). Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 190, 8053-8064.
2. Anstey, N. M., Currie, B. J., Hassell, M., Palmer, D., Dwyer, B. & Seifert, H. (2002). Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 40, 685-686.
3. Falagas, M. E., Koletsi, P. K. & Bliziotis, I. A. (2006). The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 55, 1619-1629.
4. Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnotte, B. & Martin, F. (2004). CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol 34, 336-344.
5. Guo, L., Zhang, Z., Green, K. & Stanton, R. C. (2002). Suppression of interleukin-1 beta-induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase. Biochemistry 41, 14726-14733.
6. Hunninghake, G. W. & Fauci, A. S. (1977). Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function. Clin Exp Immunol 27, 555-559.
7. Johnson, E. N., Burns, T. C., Hayda, R. A., Hospenthal, D. R. & Murray, C. K. (2007). Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis 45, 409-415.
8. Leung, W. S., Chu, C. M., Tsang, K. Y., Lo, F. H., Lo, K. F. & Ho, P. L. (2006). Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 129, 102-109.
9. Metan, G., Alp, E., Aygen, B. & Sumerkan, B. (2007). Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother 60, 197-199.
10. Murray, C. K., Yun, H. C., Griffith, M. E., Hospenthal, D. R. & Tong, M. J. (2006). Acinetobacter infection: what was the true impact during the Vietnam conflict? Clin Infect Dis 43, 383-384.
11. Olut, A. I. & Erkek, E. (2005). Early prosthetic valve endocarditis due to Acinetobacter baumannii: a case report and brief review of the literature. Scand J Infect Dis 37, 919-921.
12. Petersen, K., Riddle, M. S., Danko, J. R., Blazes, D. L., Hayden, R., Tasker, S. A. & Dunne, J. R. (2007). Trauma-related infections in battlefield casualties from Iraq. Ann Surg 245, 803-811.
13. Qiu, H., KuoLee, R., Harris, G., Van Rooijen, N., Patel, G. B. & Chen, W. (2012). Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection. PLoS ONE 7, e40019.
14. Song, J. Y., Cheong, H. J., Lee, J., Sung, A. K. & Kim, W. J. (2009). Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Int J Antimicrob Agents 33, 33-39.
15. Weinstein, R. A., Gaynes, R., Edwards, J. R. & National Nosocomial Infections Surveillance System (2005). Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41, 848-854.
16. Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P. & Edmond, M. B. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309-317.
17. Yasunami, R. & Bach, J. F. (1988). Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 18, 481-484.
18. Zimecki, M., Artym, J., Kocieba, M., Weber-Dabrowska, B., Borysowski, J. & Górski, A. (2010). Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus. Med Microbiol Immunol (Berl) 199, 71-79.
19. Zuluaga, A. F., Salazar, B. E., Rodriguez, C. A., Zapata, A. X., Agudelo, M. & Vesga, O. (2006). Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect Dis 6, 55.